Sun Pharma gets gesture for medicate trial in COVID-19 patients Kumar Jeetendra | May 30, 2020 Sun Pharmaceutical Industries Ltd. has reported that it has gotten the endorsement from the Drugs Controller General of India (DCGI) to start a clinical preliminary with Nafamostat Mesilate in COVID-19 patients. Nafamostat is endorsed in Japan for development of intense side effects of pancreatitis and treatment of Disseminated Intravascular Coagulation (DIC). “A gathering of researchers …
